AAAAAA
Results: 1-25/116
Authors:
LILLEBY W
FOSSA SD
WAEHRE HR
OLSEN DR
Citation: W. Lilleby et al., LONG-TERM MORBIDITY AND QUALITY-OF-LIFE (QOL) IN PATIENTS WITH LOCALIZED PROSTATE-CANCER UNDERGOING DEFINITIVE RADIOTHERAPY OR RADICAL PROSTATECTOMY, Psycho-oncology, 7(3), 1998, pp. 3034-3034
Authors:
FOSSA SD
AASS N
PARO G
Citation: Sd. Fossa et al., A PHASE-II STUDY OF DAUNOXOME(R) IN ADVANCED UROTHELIAL TRANSITIONAL-CELL CARCINOMA, European journal of cancer, 34(7), 1998, pp. 1131-1132
Authors:
BOFFETTA P
FICHTINGERSCHEPMAN AMJ
WEIDERPASS E
VANDIJKKNIJNENBURG HCM
STOTER G
VANOOSTEROM AT
KEIZER HJ
FOSSA SD
KALDOR J
ROY P
Citation: P. Boffetta et al., CISPLATIN - DNA-ADDUCTS AND PROTEIN-BOUND PLATINUM IN BLOOD OF TESTICULAR CANCER-PATIENTS, Anti-cancer drugs, 9(2), 1998, pp. 125-129
Authors:
HARTMANN JT
NICHOLS CR
DROZ JP
HORWICH A
GERL A
FOSSA SD
BEYER J
PONT J
SCHMOLL HJ
BOKEMEYER C
Citation: Jt. Hartmann et al., EXTRAGONADAL GERM-CELL TUMORS (EGGCT) AND HEMATOLOGIC DISORDERS - INCIDENCE AND OUTCOME FROM AN INTERNATIONAL DATABASE, Annals of oncology, 9, 1998, pp. 268-268
Authors:
RAPLEY E
TUCKER K
COLLINS F
DONALD J
FRIEDLANDER M
PENG HQ
GOSS P
HOGG D
EASTON DF
TEARE D
BISHOP DT
CROCKFORD G
FORMAN D
LEAHY M
BODMER JG
MOSES J
TONKS S
OLIVER RTD
BIGGS P
SEAL S
BARFOOT R
GILL S
PATEL S
HAMOUDI R
HUNTER R
THOMLINSON I
COOPER C
STRATTON M
HUDDART R
FOSSA SD
HEIMDAL K
Citation: E. Rapley et al., CANDIDATE REGIONS FOR TESTICULAR CANCER SUSCEPTIBILITY GENES, APMIS. Acta pathologica, microbiologica et immunologica Scandinavica, 106(1), 1998, pp. 64-70
Authors:
FOSSA SD
KAYE SB
MEAD GM
CULLEN M
DEWIT R
BODROGI I
VANGROENINGEN CJ
DEMULDER PHM
STENNING S
LALLEMAND E
DEPRIJCK L
COLLETTE L
Citation: Sd. Fossa et al., FILGRASTIM DURING COMBINATION CHEMOTHERAPY OF PATIENTS WITH POOR-PROGNOSIS METASTATIC GERM-CELL MALIGNANCY, Journal of clinical oncology, 16(2), 1998, pp. 716-724
Authors:
STEYERBERG EW
GERL A
FOSSA SD
SLEIJFER DT
DEWIT R
KIRKELS WJ
SCHMELLER N
CLEMM C
HABBEMA JDF
KEIZER HJ
Citation: Ew. Steyerberg et al., VALIDITY OF PREDICTIONS OF RESIDUAL RETROPERITONEAL MASS HISTOLOGY INNONSEMINOMATOUS TESTICULAR CANCER, Journal of clinical oncology, 16(1), 1998, pp. 269-274
Authors:
ILNER K
BLOMLIE V
FOSSA SD
Citation: K. Ilner et al., RADIATION-INDUCED INSUFFICIENCY FRACTURES AFTER DEFINITIVE PROSTATE-CANCER RADIOTHERAPY, Acta oncologica, 37(2), 1998, pp. 201-202
Authors:
FOSSA SD
FOSSABRAHAMSEN A
NOME O
Citation: Sd. Fossa et al., SEMEN QUALITY AFTER TREATMENT FOR HODGKIN,M. AND TESTICULAR CANCER, Human reproduction (Oxford. Print), 13, 1998, pp. 173-173
Authors:
HARLAND SJ
COOK PA
FOSSA SD
HORWICH A
MEAD GM
PARKINSON MC
ROBERTS JT
STENNING SP
Citation: Sj. Harland et al., INTRATUBULAR GERM-CELL NEOPLASIA OF THE CONTRALATERAL TESTIS IN TESTICULAR CANCER - DEFINING A HIGH-RISK GROUP, The Journal of urology, 160(4), 1998, pp. 1353-1357
Authors:
PAUS E
NILSSON O
BORMER OP
FOSSA SD
OTNES B
SKOVLUND E
Citation: E. Paus et al., STABILITY OF FREE AND TOTAL PROSTATE-SPECIFIC ANTIGEN IN SERUM FROM PATIENTS WITH PROSTATE CARCINOMA AND BENIGN HYPERPLASIA, The Journal of urology, 159(5), 1998, pp. 1599-1605
Authors:
AVIZIENYTE E
ROTH S
LOUKOLA A
HEMMINKI A
LOTHE RA
STENWIG AE
FOSSA SD
SALOVAARA R
AALTONEN LA
Citation: E. Avizienyte et al., SOMATIC MUTATIONS IN LKB1 ARE RARE IN SPORADIC COLORECTAL AND TESTICULAR-TUMORS, Cancer research, 58(10), 1998, pp. 2087-2090
Authors:
STENNING SP
PARKINSON MC
FISHER C
MEAD GM
COOK PA
FOSSA SD
HORWICH A
JONES WG
NEWLANDS ES
OLIVER RT
STENWIG AE
WILKINSON PM
Citation: Sp. Stenning et al., POSTCHEMOTHERAPY RESIDUAL MASSES IN GERM-CELL TUMOR PATIENTS - CONTENT, CLINICAL-FEATURES, AND PROGNOSIS, Cancer, 83(7), 1998, pp. 1409-1419
Authors:
OSEN I
FOSSA SD
MAJAK B
ROTTERUD R
BERNER A
Citation: I. Osen et al., PROGNOSTIC FACTORS IN MUSCLE-INVASIVE BLADDER-CANCER TREATED WITH RADIOTHERAPY - AN IMMUNOHISTOCHEMICAL STUDY, British Journal of Urology, 81(6), 1998, pp. 862-869
Authors:
DUELAND S
STENWIG AE
HEILO A
HOIE J
OUS S
FOSSA SD
Citation: S. Dueland et al., TREATMENT AND OUTCOME OF PATIENTS WITH EXTRAGONADAL GERM-CELL TUMORS - THE NORWEGIAN RADIUM HOSPITALS EXPERIENCE 1979-94, British Journal of Cancer, 77(2), 1998, pp. 329-335
Authors:
FOSSA SD
OLIVER RTD
STENNING SP
HORWICH A
WILKINSON P
READ G
MEAD GM
ROBERTS JT
RUSTIN G
CULLEN MH
KAYE SB
HARLAND SJ
COOK P
Citation: Sd. Fossa et al., PROGNOSTIC FACTORS FOR PATIENTS WITH ADVANCED SEMINOMA TREATED WITH PLATINUM-BASED CHEMOTHERAPY, European journal of cancer, 33(9), 1997, pp. 1380-1387
Authors:
FOSSA SD
Citation: Sd. Fossa, CURRENT POSITION OF CYTOKINES IN THE CLINICAL ONCOLOGY OF SOLID TUMORS, European journal of cancer, 33, 1997, pp. 641-641
Authors:
DUCHESNE GM
STENNING SP
AASS N
MEAD GM
FOSSA SD
OLIVER RTD
HORWICH A
READ G
ROBERTS IT
RUSTIN G
CULLEN MH
KAYE SB
HARLAND SJ
COOK PA
Citation: Gm. Duchesne et al., RADIOTHERAPY AFTER CHEMOTHERAPY FOR METASTATIC SEMINOMA - A DIMINISHING ROLE, European journal of cancer, 33(6), 1997, pp. 829-835
Authors:
DEWIT R
PAWINSKY A
STOTER G
VANOOSTEROM AT
FOSSA SD
PARIDAENS R
SVEDBERG A
DEMULDER PHM
Citation: R. Dewit et al., EORTC PHASE-II STUDY OF DAILY ORAL LINOMIDE IN METASTATIC RENAL-CELL CARCINOMA PATIENTS WITH GOOD PROGNOSTIC FACTORS, European journal of cancer, 33(3), 1997, pp. 493-495
Authors:
FOSSA SD
HORWICH A
Citation: Sd. Fossa et A. Horwich, CURRENT STATUS OF CHEMOTHERAPY IN ADVANCED SEMINOMA, European journal of cancer, 33(2), 1997, pp. 181-183
Authors:
WANDERAS EH
FOSSA SD
TRETLI S
Citation: Eh. Wanderas et al., RISK OF A 2ND GERM-CELL CANCER AFTER TREATMENT OF A PRIMARY GERM-CELLCANCER IN 2201 NORWEGIAN MALE-PATIENTS, European journal of cancer, 33(2), 1997, pp. 244-252
Authors:
WANDERAS EH
FOSSA SD
TRETLI S
Citation: Eh. Wanderas et al., RISK OF SUBSEQUENT NON-GERM CELL-CANCER AFTER TREATMENT OF GERM-CELL CANCER IN 2006 NORWEGIAN MALE-PATIENTS, European journal of cancer, 33(2), 1997, pp. 253-262
Authors:
AASS N
FOSSA SD
DAHL AA
MOE TJ
Citation: N. Aass et al., PREVALENCE OF ANXIETY AND DEPRESSION IN CANCER-PATIENTS SEEN AT THE NORWEGIAN-RADIUM-HOSPITAL, European journal of cancer, 33(10), 1997, pp. 1597-1604
Authors:
HERLOFSON BB
NORMANPEDERSEN K
REDFORS M
FOSSA SD
Citation: Bb. Herlofson et al., ORAL MUCOSAL SIDE-EFFECTS OF CYTOTOXIC CHEMOTHERAPY OF TESTICULAR CANCER - A RETROSPECTIVE STUDY, European journal of oral sciences, 105(5), 1997, pp. 523-526
Authors:
HORWICH A
SLEIJFER DT
FOSSA SD
KAYE SB
OLIVER RTD
CULLEN MH
MEAD GM
DEWIT R
DEMULDER PHM
DEARNALEY DP
COOK PA
SYLVESTER RJ
STENNING SP
Citation: A. Horwich et al., RANDOMIZED TRIAL OF BLEOMYCIN, ETOPOSIDE, AND CISPLATIN COMPARED WITHBLEOMYCIN, ETOPOSIDE, AND CARBOPLATIN IN GOOD-PROGNOSIS METASTATIC NONSEMINOMATOUS GERM-CELL CANCER - A MULTIINSTITUTIONAL MEDICAL-RESEARCH-COUNCIL -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER TRIAL, Journal of clinical oncology, 15(5), 1997, pp. 1844-1852